40: A Shot at Love with Nonprofit Insulin

Nonprofit pharmaceutical company Civica has released it's biosimilar version of Lantus long-acting insulin for $55 for a box of 5 pens—that's the list price it costs you to buy it without needing insurance, coupons, or patient assistance programs. We look at how a nonprofit business model can drastically lower prices for patients and governments.

Things we talk about:

• More info about Civica insulin and CalRx Insulin

• CalRx Patient Advisory Council Charter

• Episode on insulin pricing

• Episode on co-pay cap laws

• 119th Congress pro-healthcare scorecard

Support Beta Cell on Patreon.